RxDoctor Payments Data

Lesley Cown

Internal Medicine · Macon, GANPI 1346264702

Payments from drug & device makers

$36,242in general payments, 2019–2025

Across 675 payments — averaging $53.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$13K
  • Biohaven Pharmaceutical Holding Company Ltd.$8K
  • Biohaven Pharmaceuticals, Inc.$7K
  • AbbVie$1K
  • Novo Nordisk$1K
  • Lilly USA, LLC$766
  • plus $6K from 46 others

What the payments were for

  • Speaking & faculty fees$23,41365%
  • Travel & lodging$1,0203%
  • Food & beverage$11,80433%
  • Education$60%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$36,242 in reported general payments places this provider in the 95th percentile of 3,311 internal medicine providers in Georgia.

See all internal medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$478,231
Medicare patients
350
Services billed
9,795

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide147$212,925
MounjaroTirzepatide154$181,116
JardianceEmpagliflozin49$48,031
EliquisApixaban78$40,416
FarxigaDapagliflozin Propanediol17$27,346
JanuviaSitagliptin Phosphate24$24,262
TrulicityDulaglutide15$22,504
LinzessLinaclotide14$18,161
MyrbetriqMirabegron12$13,367
VascepaIcosapent Ethyl25$9,609
Insulin Lispro Kwikpen U-100Insulin Lispro12$6,722
SynthroidLevothyroxine Sodium64$6,219
Stiolto RespimatTiotropium Br/Olodaterol Hcl12$5,651
Rosuvastatin Calcium333$3,418
Levothyroxine Sodium302$3,331

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,052$212,925147 claims
Lilly USA, LLCMounjaro, Trulicity$766$203,621169 claims
Boehringer IngelheimJardiance, Stiolto Respimat$534$53,68261 claims
PfizerEliquis$594$40,41678 claims
AstraZenecaFarxiga$624$27,34617 claims
AbbVieLinzess, Synthroid$1,336$24,38078 claims
MerckJanuvia$238$24,26224 claims
Astellas Pharma US IncMyrbetriq$144$13,36712 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$35$3,331302 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,311 internal medicine providers in Georgia.

Other internal medicine in Macon

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →